• What best describes your title?*
  • 1. Which of the following statement(s) is correct?*
  • 2. What statement is correct about the pathophysiology and treatment of hypertrophic cardiomyopathy (HCM)?*
  • 3. According to the AHA/ACC 2024 guidelines for management of HCM, which is the recommended approach in patients with obstructive HCM and persistent symptoms despite treatment with betablockers?*
  • How many patients do you currently see each month regarding obstructive hypertrophic cardiomyopathy?
  • Learning Objectives
    Rows
  • Please provide us with feedback regarding your experience at the activity:
    Rows
  • Do you feel this activity was fair, balanced, and free of commercial bias?
  • This educational activity will result in a change in my role as a healthcare team member.
  • Based on your participation in this activity, choose the statement(s) that applies to how your role as a healthcare team member will change:
  • Attestation:

    AcademicCME designates this enduring material for a maximum of 0.75 AMA PRA Category 1 CreditsTM. Participants should claim only the credit commensurate with the extent of their participation in the activity.

    Through an agreement between the American Medical Association and the Union
    Européenne des Médecins Spécialistes, physicians may convert AMA PRA Category 1 Credit™ to an equivalent number of European CME Credits® (ECMECs®). These
    credits will be recognized by all National Accreditation Authorities in Europe with which the UEMS has a signed agreement of recognition of credits.

  • Date
     - -
    2 digit month, 2 digit day, 4 digit year
  • Should be Empty: